IDXG (INTERPACE BIOSCIENCES INC)
Insider Trading Activity
Every open-market purchase and sale reported by IDXG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-02-02 | Robert J. Gorman | Director | A | — | — |
| 2020-12-02 | JACK E STOVER | — | A | — | — |
| 2020-12-02 | Thomas W. Burnell | President and CEO | A | — | — |
| 2020-07-31 | James Early | — | M | — | — |
| 2020-07-13 | Robert J. Gorman | Director | A | — | — |
| 2020-07-10 | JOSEPH D KEEGAN | Director | A | — | — |
| 2020-07-10 | Fortunato R. Rocca | Director | A | — | — |
| 2020-07-10 | STEPHEN J SULLIVAN | Director | A | — | — |
| 2020-04-06 | JACK E STOVER | President and CEO | A | — | — |
| 2020-02-10 | JACK E STOVER | President and CEO | — | — | — |
| 2020-02-10 | Gregory Richard | Chief Commercial Officer | — | — | — |
| 2020-02-03 | Fred S. Knechtel | Chief Financial Officer | A | — | — |
| 2020-01-31 | Robert J. Gorman | Director | A | — | — |
| 2020-01-31 | James Early | Chief Financial Officer | A | — | — |
| 2020-01-24 | JACK E STOVER | President and CEO | A | — | — |
| 2020-01-24 | Gregory Richard | Chief Commerical Officer | A | — | — |
| 2020-01-17 | Eric B. Lev | Director | MIXED | — | — |
| 2020-01-17 | Ampersand 2018 Limited Partnership | 10%+ Owner | MIXED | — | — |
| 2020-01-17 | Laurence McCarthy | Director | MIXED | — | — |
| 2019-10-18 | Ampersand 2018 Limited Partnership | 10%+ Owner | A | — | — |
| 2019-10-18 | Eric B. Lev | Director | A | — | — |
| 2019-10-15 | Eric B. Lev | Director | MIXED | — | — |
| 2019-10-15 | Ampersand 2018 Limited Partnership | 10%+ Owner | MIXED | — | — |
| 2016-03-03 | Nat Krishnamurti | Interim CFO | A | — | — |
| 2016-02-05 | JOSEPH D KEEGAN | Director | A | — | — |
| 2016-02-05 | STEPHEN J SULLIVAN | Director | A | — | — |
| 2016-02-05 | Harry Glorikian | Director | A | — | — |
| 2016-02-05 | JACK E STOVER | Interim President and CEO | A | — | — |
| 2015-12-30 | Graham G Miao | CFO | F | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | President and CEO | 45,000 | — |
| — | President and CEO | 6,054 | — |
| — | Director | 3,752 | — |
| — | Chief Commercial Officer | 1,701 | — |
| — | Chief Financial Officer | 1,425 | — |
| — | CFO | 424 | — |
| — | Director | 255 | — |
| — | Director | 255 | — |
| — | Director | 196 | — |
| — | Interim CFO | 18 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IDXG quote page; the site-wide leaderboard is on the insider transactions hub.